<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>2240</number>
    <updateDate>2023-01-13T04:49:06Z</updateDate>
    <updateDateIncludingText>2023-01-13T04:49:06Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2006-02-02</introducedDate>
    <congress>109</congress>
    <committees>
      <item>
        <systemCode>ssfi00</systemCode>
        <name>Finance Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2006-02-02T16:36:02Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>To amend part D of title XVIII of the Social Security Act to extend the 2006 and 2007 initial enrollment periods for the Medicare prescription drug benefit and suspend the late enrollment penalty through December 31, 2007, to permit Medicare beneficiaries to change enrollment in a prescription drug plan during the first 12 months of enrollment, and to prevent changes in formularies other than at the time of open enrollment periods and only with advance notice.</title>
        <congress>109</congress>
        <number>5263</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2006-05-15</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2006-02-02</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S512-513)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2006-02-02</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S512)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-02-02</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>L000261</bioguideId>
        <fullName>Sen. Levin, Carl [D-MI]</fullName>
        <firstName>CARL</firstName>
        <lastName>LEVIN</lastName>
        <party>D</party>
        <state>MI</state>
        <middleName>MILTON</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S000770</bioguideId>
        <fullName>Sen. Stabenow, Debbie [D-MI]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Stabenow</lastName>
        <party>D</party>
        <state>MI</state>
        <sponsorshipDate>2006-02-02</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Coinsurance</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Cost control</name>
        </item>
        <item>
          <name>Crime and Law Enforcement</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>Finance and Financial Sector</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Health care fraud</name>
        </item>
        <item>
          <name>Medicaid</name>
        </item>
        <item>
          <name>Medical economics</name>
        </item>
        <item>
          <name>Medicare</name>
        </item>
        <item>
          <name>Pharmacies</name>
        </item>
        <item>
          <name>Prescription pricing</name>
        </item>
        <item>
          <name>Quality of care</name>
        </item>
        <item>
          <name>Social Welfare</name>
        </item>
        <item>
          <name>Subsidies</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2006-02-02</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2006-03-16T22:34:57Z</updateDate>
        <text><![CDATA[ <p>Medicare Part D Reform Act of 2006 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to prohibit the prescription drug plan sponsor of a prescription drug plan from removing a covered part D drug from the plan formulary or changing the preferred or tiered cost-sharing status of such a drug, except between September 1 and October 31 of any year, effective only as of January 1 of the following year.</p> <p>Amends SSA title XI to exempt from certain criminal penalties any waiver or reduction of patient cost-sharing by pharmacies under pharmaceutical patient assistance programs.</p> <p>Amends SSA title XVIII part D with respect to the reduction in cost-sharing below the out-of-pocket threshold for individuals with income below 135% of the poverty line. Requires waiver of such copayments in the case of a full-benefit dual eligible individual who is unable to pay the applicable copayment.</p> <p>Gives the Secretary the authority to negotiate prescription drug prices with manufacturers of covered part D drugs.</p>]]></text>
      </summary>
    </summaries>
    <title>Medicare Part D Reform Act of 2006</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Medicare Part D Reform Act of 2006</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend title XVIII to reform the Medicare prescription drug program.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Medicare Part D Reform Act of 2006</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2006-02-02T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-109s2240is/xml/BILLS-109s2240is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2006-02-02</actionDate>
      <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S512-513)</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
